Revenue Model & Commercialization

Structured Path to Platform Monetization

Market Opportunity

LATAMED AI intends to pursue a diversified commercialization strategy centered on software licensing, digital platform access, and coordinated healthcare service infrastructure.

The Company has not generated revenue and has not entered into binding commercial agreements. Commercial deployment will require completion of platform development, regulatory compliance where applicable, strategic partnerships, and additional capital investment.

AI Platform Licensing

The Company anticipates commercializing its artificial intelligence analytics platform through subscription-based licensing arrangements with healthcare providers, clinics and specialty practices, hospital systems, healthcare networks, and private healthcare groups.

Licensing Structures May Include:

Recurring subscription fees, enterprise licensing agreements, tiered feature-based access models, and specialty- specific module subscriptions. Disease-focused modules may be offered individually or as part of an integrated enterprise platform.

Telehealth Infrastructure Access

The Company intends to offer access to its telehealth and coordination infrastructure through structured platform access models, which may include per-consultation platform usage fees, subscription-based provider access, enterprise-level telehealth infrastructure agreements, and API-based integration licensing. Telehealth monetization will depend on regulatory compliance and operational deployment in applicable jurisdictions.

Hybrid Care Coordination Fees

The Company intends to offer access to its telehealth and coordination infrastructure through structured platform access models, which may include per-consultation platform usage fees, subscription-based provider access, enterprise-level telehealth infrastructure agreements, and API-based integration licensing. Telehealth monetization will depend on regulatory compliance and operational deployment in applicable jurisdictions.

Phased Commercial Deployment

The Company intends to pursue a staged commercialisation approach, which may include pilot programs, strategic provider partnerships, limited geographic rollouts, and incremental feature deployment.Scalability will depend on technical development progress, regulatory requirements, market adoption, capital availability, and operational infrastructure readiness.

Long-Term Monetization Vision

LATAMED AI's long-term strategy is centered on building a scalable healthcare intelligence infrastructure capable of supporting multi-site provider networks, cross-border digital health deployments, specialty-specific analytics expansion, and integrated telehealth and care coordination ecosystems. Commercial success will depend on successful development, regulatory navigation, and market acceptance.

Latin America Market Strategy

Healthcare systems across Latin America face significant structural challenges, including uneven access to specialist care, geographic disparities in service availability, limited advanced diagnostic infrastructure in certain regions, growing chronic disease burdens, fragmented care coordination frameworks, and increasing demand for telehealth-enabled services.At the same time, the region is experiencing rapid growth in mobile connectivity, digital health adoption, private ealthcare investment, government interest in healthcare modernization, and cross-border digital service expansion.

LATAMED AI's strategic focus is aligned with these macroeconomic and healthcare transformation trends.

Why Latin America

The Company has identified Latin America as an initial geographic focus due to:

Digital Infrastructure

Expanding digital infrastructure across major urban centers

Telemedicine Adoption

Growing telemedicine adoption and patient demand for convenient care access

System Inefficiencies

Operational inefficiencies within legacy healthcare delivery systems

Colombia as a Prospective Expansion Market

Colombia has been identified as a prospective initial expansion market due to a growing private healthcare sector, increasing adoption of telemedicine services, supportive digital health initiatives, and expanding healthcare infrastructure in urban regions.

The Company has not commenced operations in Colombia and has not secured regulatory approvals required to initiate medical services in that jurisdiction. Any future expansion will require compliance with local healthcare regulations, telemedicine laws, and professional licensing standards.

Phased Deployment Strategy

LATAMED AI intends to pursue a phased geographic expansion model, which may include limited pilot programs, strategic provider partnerships, regulatory evaluation initiatives, and staged digital infrastructure rollouts.

Scalability will depend on regulatory compliance, capital availability, technical deployment readiness, and strategic alignment with local healthcare stakeholders.

Long-Term Market Positioning

The Company believes that emerging markets with expanding digital connectivity and healthcare modernization initiatives may provide opportunities for AI-enabled healthcare analytics and coordinated care infrastructure. LATAMED AI is positioning its platform to align with these regional dynamics while maintaining flexibility for expansion into additional international markets over time.

Ready to Transform Healthcare Delivery?

Discover how LATAMED AI’s intelligent healthcare infrastructure can support your organization’s strategic objectives.